CRS - CYTOKINE RELEASE SYNDROME
Clinical trials for CRS - CYTOKINE RELEASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CRS - CYTOKINE RELEASE SYNDROME trials appear
Sign up with your email to follow new studies for CRS - CYTOKINE RELEASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Emergency rescue plan for cancer Treatment's dangerous side effects
Disease control Recruiting nowThis early-stage study is testing emergency rescue drugs for patients who develop severe, life-threatening immune reactions after receiving CAR-T cell cancer therapy. The study will enroll up to 10 adults already participating in CAR-T cell trials at the University of Pennsylvani…
Matched conditions: CRS - CYTOKINE RELEASE SYNDROME
Phase: EARLY_PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Scientists hunt for early clues to stop dangerous cancer treatment reactions
Knowledge-focused Recruiting nowThis study aims to better predict and detect dangerous side effects, like Cytokine Release Syndrome (CRS), in blood cancer patients receiving new immunotherapies. Researchers will monitor 100 patients using wireless sensors to track vital signs and blood tests to measure immune r…
Matched conditions: CRS - CYTOKINE RELEASE SYNDROME
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC